Literature DB >> 8499051

Does phenobarbital used for febrile seizures cause sleep disturbances?

D G Hirtz1, T C Chen, K B Nelson, S Sulzbacher, J R Farwell, J H Ellenberg.   

Abstract

The effect of phenobarbital on total sleep time, night awakenings, and lengthy awakenings was examined as part of a randomized trial of children with febrile seizures; information about sleep patterns was gathered by parental observation. Children were between ages 8-36 months at enrollment and were examined subsequently for 2 1/2 years. Night awakenings were not more common in children assigned to phenobarbital except for those who were poor sleepers at the beginning of the study. Total sleep time was no different in children assigned to phenobarbital than in those assigned to placebo. It is concluded that sleep problems reported in most young children with febrile seizures treated with phenobarbital did not exceed those reported in children treated with placebo, but a subset of predisposed children did experience an increase in night awakenings.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499051     DOI: 10.1016/0887-8994(93)90042-b

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

Review 1.  Prophylactic drug management for febrile seizures in children.

Authors:  Martin Offringa; Richard Newton; Martinus A Cozijnsen; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2017-02-22

2.  Phenobarbital for childhood epilepsy: systematic review.

Authors:  Deb K Pal
Journal:  Paediatr Perinat Drug Ther       Date:  2006-05

3.  Born Under COVID-19 Pandemic Conditions: Infant Regulatory Problems and Maternal Mental Health at 7 Months Postpartum.

Authors:  Anna Perez; Ariane Göbel; Lydia Yao Stuhrmann; Steven Schepanski; Dominique Singer; Carola Bindt; Susanne Mudra
Journal:  Front Psychol       Date:  2022-01-26

4.  Prophylactic drug management for febrile seizures in children.

Authors:  Martin Offringa; Richard Newton; Sarah J Nevitt; Katerina Vraka
Journal:  Cochrane Database Syst Rev       Date:  2021-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.